Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement

NCT04369794 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT04369794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04369794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
Lead sponsor
University of Campinas, Brazil
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2020
Completion date
August 2, 2023
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg, covid-19, sars-cov 2, therapeutic vaccine, transmission